Opill: Game-Changing Over-the-Counter Birth Control Hits Shelves at CVS & Walgreens

Detroit, Michigan – Opill, the first oral contraceptive approved for over-the-counter use in the United States, will soon be available to consumers without a prescription. Perrigo, the company behind the product, announced that Opill will be on sale in stores and online this month, offering a one-month supply for $19.99 and a three-month supply for $49.99.

According to executive vice president Triona Schmelter, Opill will be easily accessible for purchase online, with plans to have it stocked in major retailers and pharmacies. The product, once available, can be found in the family planning section of most stores and on Opill.com.

Perrigo has emphasized that Opill is 98% effective in preventing pregnancy when taken as directed. This new over-the-counter option provides convenience and affordability for those seeking birth control.

Retail chains like Walgreens and CVS have expressed their support for Opill, with plans to offer the product to their customers. Additional online retailers may also carry the contraceptive, further expanding its accessibility.

Advocacy groups, like Free the Pill, have called for affordability in pricing to ensure broader access to Opill. Perrigo has responded by committing to a cost assistance program for low-income and uninsured individuals.

Health professionals, such as Dr. Colleen Denny and Dr. Ashley Brant, have highlighted the safety and effectiveness of Opill. As a progestin-only contraceptive, it offers a viable option for individuals who may have contraindications to combination birth control pills.

Overall, Opill’s availability as an over-the-counter option represents a significant advancement in reproductive health access in the United States. While traditional avenues for obtaining birth control remain, this new option provides an additional choice for consumers. The introduction of Opill reflects a broader effort to make essential health products more accessible and affordable for all individuals.